TAM
IBB icon

Titleist Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Titleist Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$668K Buy
3,514
+259
+8% +$44.5K 0.05% 241
2026
Q1 		$550K Buy
3,255
+411
+14% +$70.3K 0.04% 244
2025
Q4 		$480K Buy
+2,844
New +$462K 0.04% 230

Other funds holding IBB

WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
CA
Cumberland Advisors Sarasota, Florida $284M AUM 27.11% 1-Year Est. Return
FNFDCM
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

Titleist Asset Management's IBB Position: Q2 2026 in Review

Titleist Asset Management increased its iShares Biotechnology ETF (IBB) stake by 8% in Q2 2026, buying an estimated $44.5K and bringing the position to 3,514 shares worth $668K. The position accounts for 0.05% of the portfolio, ranked #241.

Titleist Asset Management first reported a position in IBB in Q4 2025 and has held it in 3 quarters since. 285 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Titleist Asset Management held 3,514 shares of iShares Biotechnology ETF worth $668K as of Q2 2026.
  • Titleist Asset Management bought 259 iShares Biotechnology ETF shares in Q2 2026, an estimated $44.5K.
  • iShares Biotechnology ETF made up 0.05% of Titleist Asset Management's portfolio in Q2 2026, its #241 holding.
  • Titleist Asset Management first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 3 quarters since.
  • 285 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Titleist Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.